Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers

For many years, luteinizing hormone-releasing hormone or gonadotropin-releasing hormone (GnRH) analogs have been used to treat androgen or estrogen-dependent tumors. However, emerging evidence shows that the GnRH receptor (GnRH-R) is overexpressed in several cancer cells, including ovarian, endometr...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido, Maritza P., Hernandez, Andrea, Vega, Margarita, Araya, Eyleen, Romero, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086188/
https://www.ncbi.nlm.nih.gov/pubmed/37056674
http://dx.doi.org/10.3389/fendo.2023.1143261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086188/
https://www.ncbi.nlm.nih.gov/pubmed/37056674
http://dx.doi.org/10.3389/fendo.2023.1143261

Ejemplares similares